SLNO Archived Articles
Soleno Therapeutics, Inc. (SLNO): Developing Novel Therapeutics for Rare Diseases
Published on March 14, 2025
Soleno Therapeutics (SLNO): Pioneering a Treatment for Prader-Willi Syndrome
Published on November 17, 2024
Soleno Therapeutics, Inc. (NASDAQ:SLNO): A Promising Rare Disease Biotech with Significant Upside Potential
Published on September 24, 2024